• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有晚期肺动脉高压和混合性结缔组织病的患者接受免疫抑制治疗后的十年生存率。

Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy.

作者信息

Dahl M, Chalmers A, Wade J, Calverley D, Munt B

机构信息

Department of Medicine, University of British Columbia, Vancouver, Canada.

出版信息

J Rheumatol. 1992 Nov;19(11):1807-9.

PMID:1491407
Abstract

Pulmonary hypertension is the most frequent cause of death in patients with mixed connective tissue disease. The pulmonary hypertension is progressive and difficult to treat effectively. These patients experience considerable morbidity secondary to diminished cardiac function. We describe a case in which sequential administration of cyclophosphamide and cyclosporine A favorably altered the clinical and hemodynamic course of this serious complication.

摘要

肺动脉高压是混合性结缔组织病患者最常见的死亡原因。肺动脉高压呈进行性发展且难以有效治疗。这些患者因心功能减退而出现相当程度的发病情况。我们描述了一例病例,其中序贯给予环磷酰胺和环孢素A有利地改变了这一严重并发症的临床和血流动力学进程。

相似文献

1
Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy.一名患有晚期肺动脉高压和混合性结缔组织病的患者接受免疫抑制治疗后的十年生存率。
J Rheumatol. 1992 Nov;19(11):1807-9.
2
Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.狼疮和混合性结缔组织病相关肺动脉高压的免疫抑制治疗:23例回顾性分析
Arthritis Rheum. 2008 Feb;58(2):521-31. doi: 10.1002/art.23303.
3
Pulmonary hypertension in a child with mixed connective tissue disease.
J Rheumatol. 1979 Nov-Dec;6(6):700-4.
4
[Fatal pulmonary hypertension in Sharp syndrome (M.C.T.D.) with pulmonary fibrosis].夏普综合征(混合性结缔组织病)合并肺纤维化导致的致命性肺动脉高压
Rev Med Brux. 1990 Jan-Feb;11(1-2):26-30.
5
Fatal primary pulmonary hypertension in mixed connective tissue disease.
Z Rheumatol. 1981 Jan-Feb;40(1):25-9.
6
Combined effects of diltiazem and oxygen in pulmonary hypertension of mixed connective tissue disease.
J Rheumatol. 1994 Sep;21(9):1763-5.
7
[Pulmonary arterial hypertension in connective tissue disease].[结缔组织病中的肺动脉高压]
Rev Mal Respir. 2006 Sep;23(4 Suppl):13S61-72.
8
[Evaluation of survival in mixed connective tissue disease (MCTD)].
Orv Hetil. 2002 Nov 10;143(45):2543-8.
9
[A case of mixed connective tissue disease with pulmonary hypertension (author's transl)].1例混合性结缔组织病合并肺动脉高压(作者译)
Kokyu To Junkan. 1978 Sep;26(9):897-902.
10
Effect of steroid pulse therapy on mixed connective tissue disease with pulmonary arterial hypertension.类固醇冲击疗法对合并肺动脉高压的混合性结缔组织病的影响。
Ann Rheum Dis. 2005 Aug;64(8):1236-7. doi: 10.1136/ard.2004.029074.

引用本文的文献

1
High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4.高迁移率族蛋白 B1 通过激活 Toll 样受体 4 促进实验性肺动脉高压的发病机制。
Mol Med. 2013 Feb 8;18(1):1509-18. doi: 10.2119/molmed.2012.00283.
2
Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus.系统性硬皮病和系统性红斑狼疮相关肺动脉高压。
Eur Respir Rev. 2011 Dec;20(122):277-86. doi: 10.1183/09059180.00003811.
3
Treatment of pulmonary hypertension secondary to connective tissue diseases.
结缔组织病继发肺动脉高压的治疗。
Thorax. 1999 Mar;54(3):273-7. doi: 10.1136/thx.54.3.273.
4
Improvement of severe pulmonary hypertension in a patient with SLE.系统性红斑狼疮患者严重肺动脉高压的改善
Ann Rheum Dis. 1996 Aug;55(8):561-2. doi: 10.1136/ard.55.8.561.
5
Pulmonary vascular reactivity in severe pulmonary hypertension associated with mixed connective tissue disease.与混合性结缔组织病相关的重度肺动脉高压中的肺血管反应性
Thorax. 1995 Jan;50(1):96-7. doi: 10.1136/thx.50.1.96.
6
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.环孢素。对其药效学和药代动力学特性以及在免疫调节紊乱中的治疗应用的综述。
Drugs. 1993 Jun;45(6):953-1040. doi: 10.2165/00003495-199345060-00007.